Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EKB-569 in Advanced Colorectal Cancer
NCT00072748Phase 2Completed
- Sponsor
- Pfizer
- Primary completion
- Oct 2004
- Modality
- Small Molecules
01
Overview
Phase 2, open-label, single-arm trial of pelitinib in colorectal cancer (CRC), sponsored by Pfizer. Primary endpoint: Clinical Activity. Status: completed.
02
Drugs
pelitinib
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT00072748.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00072748.